Pre-market Movers For Nov 5 (AOL, CVS, ENDP, KORS, CYTX, GTAT, IMGN, BSFT, OTEX)

(RTTNews) - Gainers:

AOL Inc. (AOL) is gaining 3 percent to $40.00. The company's third quarter profit plunged from the previous year period. At the same time, total revenues rose 6 percent and topped the consensus estimate. Global advertising revenue for the quarter grew 14 percent.

CVS Caremark Corp. (CVS) is up 2 percent to $63.30. The company's third quarter profit and net revenues were higher than in the year-ago quarter. The company raised its fiscal year adjusted earnings guidance.

Endo Health Solutions Inc. (ENDP) is jumping 28 percent to $56.25. The company agreed to acquire specialty pharmaceutical company Paladin Labs Inc. (PLB.TO) in a stock and cash transaction valued at about $1.6 billion. The deal is expected to be immediately accretive to Endo's 2014 adjusted earnings per share.

Michael Kors Holdings Ltd. (KORS) is up 4 percent to $78.00. The company's second quarter results topped Wall Street view. The company also raised its fiscal 2014 guidance, in-line with market view.

Cytori Therapeutics, Inc. (CYTX) is surging 38 percent to $2.90. The company announced a partnership with Lorem Vascular to commercialize Cytori Cell Therapy for the cardiovascular, renal and diabetes markets in China, Hong Kong, Malaysia, Singapore and Australia. Lorem Vascular committed to pay up to $531 million in license fees, opening product purchase commitments and Cytori equity purchases.

GT Advanced Technologies Inc. (GTAT) is gaining 24 percent to $10.38 based on the news that it has entered into a multi-year supply agreement with Apple Inc. (AAPL) to provide sapphire material.

Decliners:

ImmunoGen, Inc. (IMGN) is down 16 percent to $13.90. The company announced the decision to stop the IMGN901 Phase II SCLC study, following the recommendation of the trial's independent Data Monitoring Committee that the addition of IMGN901, a CD56-targeting ADC, to etoposide/carboplatin was unlikely to demonstrate a sufficient improvement in progression-free survival compared to E/C alone to justify continuation of the trial.

BroadSoft, Inc. (BSFT) is falling 18 percent to $26.95 following the release of its quarterly results.

Trading halt:

Trading in shares of Open Text Corp. (OTEX) was halted. The company agreed to acquire GXS Group, Inc. for purchase price of $1.165 billion. The company expects the deal to be accretive to its adjusted earnings for fiscal year 2014.